These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 17055551)
1. A study on antigenicity and receptor-binding ability of fragment 450-650 of the spike protein of SARS coronavirus. Zhao J; Wang W; Yuan Z; Jia R; Zhao Z; Xu X; Lv P; Zhang Y; Jiang C; Gao XM Virology; 2007 Mar; 359(2):362-70. PubMed ID: 17055551 [TBL] [Abstract][Full Text] [Related]
2. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies. He Y; Lu H; Siddiqui P; Zhou Y; Jiang S J Immunol; 2005 Apr; 174(8):4908-15. PubMed ID: 15814718 [TBL] [Abstract][Full Text] [Related]
3. Calreticulin as a hydrophilic chimeric molecular adjuvant enhances IgG responses to the spike protein of severe acute respiratory syndrome coronavirus. Qiu X; Hong C; Li Y; Bao W; Gao XM Microbiol Immunol; 2012 Aug; 56(8):554-61. PubMed ID: 22530918 [TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Li W; Moore MJ; Vasilieva N; Sui J; Wong SK; Berne MA; Somasundaran M; Sullivan JL; Luzuriaga K; Greenough TC; Choe H; Farzan M Nature; 2003 Nov; 426(6965):450-4. PubMed ID: 14647384 [TBL] [Abstract][Full Text] [Related]
5. Antigenicity and receptor-binding ability of recombinant SARS coronavirus spike protein. Ho TY; Wu SL; Cheng SE; Wei YC; Huang SP; Hsiang CY Biochem Biophys Res Commun; 2004 Jan; 313(4):938-47. PubMed ID: 14706633 [TBL] [Abstract][Full Text] [Related]
6. Importance of cholesterol-rich membrane microdomains in the interaction of the S protein of SARS-coronavirus with the cellular receptor angiotensin-converting enzyme 2. Glende J; Schwegmann-Wessels C; Al-Falah M; Pfefferle S; Qu X; Deng H; Drosten C; Naim HY; Herrler G Virology; 2008 Nov; 381(2):215-21. PubMed ID: 18814896 [TBL] [Abstract][Full Text] [Related]
7. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. Glowacka I; Bertram S; Herzog P; Pfefferle S; Steffen I; Muench MO; Simmons G; Hofmann H; Kuri T; Weber F; Eichler J; Drosten C; Pöhlmann S J Virol; 2010 Jan; 84(2):1198-205. PubMed ID: 19864379 [TBL] [Abstract][Full Text] [Related]
8. A novel cell-based binding assay system reconstituting interaction between SARS-CoV S protein and its cellular receptor. Chou CF; Shen S; Tan YJ; Fielding BC; Tan TH; Fu J; Xu Q; Lim SG; Hong W J Virol Methods; 2005 Jan; 123(1):41-8. PubMed ID: 15582697 [TBL] [Abstract][Full Text] [Related]
9. Endocytosis of the receptor-binding domain of SARS-CoV spike protein together with virus receptor ACE2. Wang S; Guo F; Liu K; Wang H; Rao S; Yang P; Jiang C Virus Res; 2008 Sep; 136(1-2):8-15. PubMed ID: 18554741 [TBL] [Abstract][Full Text] [Related]
10. Expression cloning of functional receptor used by SARS coronavirus. Wang P; Chen J; Zheng A; Nie Y; Shi X; Wang W; Wang G; Luo M; Liu H; Tan L; Song X; Wang Z; Yin X; Qu X; Wang X; Qing T; Ding M; Deng H Biochem Biophys Res Commun; 2004 Mar; 315(2):439-44. PubMed ID: 14766227 [TBL] [Abstract][Full Text] [Related]
11. A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity. He Y; Li J; Jiang S Biochem Biophys Res Commun; 2006 May; 344(1):106-13. PubMed ID: 16615996 [TBL] [Abstract][Full Text] [Related]
12. Cleavage of the SARS coronavirus spike glycoprotein by airway proteases enhances virus entry into human bronchial epithelial cells in vitro. Kam YW; Okumura Y; Kido H; Ng LF; Bruzzone R; Altmeyer R PLoS One; 2009 Nov; 4(11):e7870. PubMed ID: 19924243 [TBL] [Abstract][Full Text] [Related]
13. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936 [TBL] [Abstract][Full Text] [Related]
14. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines. He Y; Zhu Q; Liu S; Zhou Y; Yang B; Li J; Jiang S Virology; 2005 Mar; 334(1):74-82. PubMed ID: 15749124 [TBL] [Abstract][Full Text] [Related]
15. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. Fukushi S; Mizutani T; Saijo M; Matsuyama S; Miyajima N; Taguchi F; Itamura S; Kurane I; Morikawa S J Gen Virol; 2005 Aug; 86(Pt 8):2269-2274. PubMed ID: 16033974 [TBL] [Abstract][Full Text] [Related]
16. The spike protein of severe acute respiratory syndrome (SARS) is cleaved in virus infected Vero-E6 cells. Wu XD; Shang B; Yang RF; Yu H; Ma ZH; Shen X; Ji YY; Lin Y; Wu YD; Lin GM; Tian L; Gan XQ; Yang S; Jiang WH; Dai EH; Wang XY; Jiang HL; Xie YH; Zhu XL; Pei G; Li L; Wu JR; Sun B Cell Res; 2004 Oct; 14(5):400-6. PubMed ID: 15450134 [TBL] [Abstract][Full Text] [Related]
17. Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. Chen Z; Zhang L; Qin C; Ba L; Yi CE; Zhang F; Wei Q; He T; Yu W; Yu J; Gao H; Tu X; Gettie A; Farzan M; Yuen KY; Ho DD J Virol; 2005 Mar; 79(5):2678-88. PubMed ID: 15708987 [TBL] [Abstract][Full Text] [Related]
18. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein. He Y; Li J; Li W; Lustigman S; Farzan M; Jiang S J Immunol; 2006 May; 176(10):6085-92. PubMed ID: 16670317 [TBL] [Abstract][Full Text] [Related]
19. Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus. van den Brink EN; Ter Meulen J; Cox F; Jongeneelen MA; Thijsse A; Throsby M; Marissen WE; Rood PM; Bakker AB; Gelderblom HR; Martina BE; Osterhaus AD; Preiser W; Doerr HW; de Kruif J; Goudsmit J J Virol; 2005 Feb; 79(3):1635-44. PubMed ID: 15650189 [TBL] [Abstract][Full Text] [Related]
20. Design and biological activities of novel inhibitory peptides for SARS-CoV spike protein and angiotensin-converting enzyme 2 interaction. Ho TY; Wu SL; Chen JC; Wei YC; Cheng SE; Chang YH; Liu HJ; Hsiang CY Antiviral Res; 2006 Feb; 69(2):70-6. PubMed ID: 16337697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]